BioStock: WntResearch CEO comments on reverse acquisition

After the disappointing results with Foxy-5 last year, WntResearch has been looking for a way to secure shareholder value. Now, The Board of Directors propose a reverse acquisition of the Swedish insuretech company OPSY for approximately SEK 120 million. BioStock contacted Per Norlén, CEO of WntResearch, to find out more.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/02/wntresearch-ceo-comments-on-reverse-acquisition/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se